NO20091267L - Compositions and methods to prevent cancer with cupredoxins - Google Patents

Compositions and methods to prevent cancer with cupredoxins

Info

Publication number
NO20091267L
NO20091267L NO20091267A NO20091267A NO20091267L NO 20091267 L NO20091267 L NO 20091267L NO 20091267 A NO20091267 A NO 20091267A NO 20091267 A NO20091267 A NO 20091267A NO 20091267 L NO20091267 L NO 20091267L
Authority
NO
Norway
Prior art keywords
cupredoxins
compositions
methods
prevent cancer
cancer
Prior art date
Application number
NO20091267A
Other languages
Norwegian (no)
Inventor
Ananda Chakrabarty
Tapas Das Gupta
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of NO20091267L publication Critical patent/NO20091267L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/104Pseudomonadales, e.g. Pseudomonas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NO20091267A 2006-09-14 2009-03-26 Compositions and methods to prevent cancer with cupredoxins NO20091267L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84435806P 2006-09-14 2006-09-14
PCT/US2007/078371 WO2008033987A2 (en) 2006-09-14 2007-09-13 Compositions and methods to prevent cancer with cupredoxins

Publications (1)

Publication Number Publication Date
NO20091267L true NO20091267L (en) 2009-06-04

Family

ID=39184582

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091267A NO20091267L (en) 2006-09-14 2009-03-26 Compositions and methods to prevent cancer with cupredoxins

Country Status (13)

Country Link
EP (1) EP2061498A4 (en)
JP (2) JP2010503409A (en)
KR (1) KR20090059152A (en)
CN (1) CN101595124A (en)
AU (1) AU2007296429A1 (en)
BR (1) BRPI0714987A2 (en)
CA (1) CA2663498A1 (en)
IL (1) IL197602A0 (en)
MX (1) MX2009002787A (en)
NO (1) NO20091267L (en)
RU (1) RU2009113812A (en)
SG (1) SG174784A1 (en)
WO (1) WO2008033987A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7556810B2 (en) 2005-07-19 2009-07-07 The Board Of Trustees Of The University Of Ilinois Compositions and methods to control angiogenesis with cupredoxins
US9096663B2 (en) 2001-02-15 2015-08-04 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
US7381701B2 (en) 2001-02-15 2008-06-03 The Borad Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
AP2007003959A0 (en) 2004-10-07 2007-04-30 Ananda Chakrabarty Cupredoxin derived transport agents and methods ofuse thereof
US9968685B2 (en) 2004-10-07 2018-05-15 Brad N. Taylor Methods to treat cancer with cupredoxins
US10675326B2 (en) 2004-10-07 2020-06-09 The Board Of Trustees Of The University Of Illinois Compositions comprising cupredoxins for treating cancer
US9598470B2 (en) * 2004-10-07 2017-03-21 Craig W. Beattie Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways
US9434770B2 (en) 2004-10-07 2016-09-06 Tapas K Das Gupta Modified cupredoxin derived peptides
MX2008000994A (en) 2005-07-19 2008-03-19 Univ Illinois Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof.
KR20090095626A (en) 2006-12-04 2009-09-09 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 COMPOSITIONS AND METHODS TO TREAT CANCER WITH CpG RICH DNA AND CUPREDOXINS
AU2008212788A1 (en) 2007-02-08 2008-08-14 The Board Of Trustees Of The University Of Illinois Compositions and methods to prevent cancer with cupredoxins
KR102718038B1 (en) * 2017-09-29 2024-10-16 온크그노스틱스 게엠베하 Determining risk for neoplasia and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491394B2 (en) * 2001-02-15 2009-02-17 The Board Of Trustees Of The University Of Illinois Cytotoxic factors for modulating cell death
CN1506375A (en) * 2002-12-12 2004-06-23 浙江养生堂天然药物研究所有限公司 Bacterial protein azurin with broad-spectrum anti-tumor effect, its use and pharmaceutical composition containing it
AP2007003959A0 (en) * 2004-10-07 2007-04-30 Ananda Chakrabarty Cupredoxin derived transport agents and methods ofuse thereof
CA2608512A1 (en) * 2005-05-20 2007-02-15 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
KR20080034905A (en) * 2005-07-19 2008-04-22 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 Compositions and Methods of Controlling Angiogenesis with Cupredoxin

Also Published As

Publication number Publication date
AU2007296429A1 (en) 2008-03-20
IL197602A0 (en) 2011-08-01
EP2061498A2 (en) 2009-05-27
WO2008033987A3 (en) 2009-04-30
JP2010503409A (en) 2010-02-04
CA2663498A1 (en) 2008-03-20
KR20090059152A (en) 2009-06-10
RU2009113812A (en) 2010-10-20
BRPI0714987A2 (en) 2013-07-30
CN101595124A (en) 2009-12-02
WO2008033987A2 (en) 2008-03-20
MX2009002787A (en) 2009-08-27
JP2014050390A (en) 2014-03-20
SG174784A1 (en) 2011-10-28
EP2061498A4 (en) 2009-11-04

Similar Documents

Publication Publication Date Title
NO20200775A1 (en) Methods and compositions for treating cancer
CR10667A (en) COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER
DK2063907T3 (en) METHODS AND COMPOSITIONS BASED ON DIFTERY TOXIN-INTERLEUKIN-3 CONJUGATES
BRPI0716325A2 (en) ANTIMICROBIAN COMPOSITION
SMAP200900058A (en) Compounds and compositions as proteinachinase inhibitors
SM201000108B (en) Compounds and compositions as proteinachinase inhibitors
SMAP200900020A (en) Compounds and compositions as proteinachinase inhibitors
SMAP200900031A (en) Compounds and compositions as proteinachinase inhibitors
EP2041267A4 (en) Compositions and methods for enhancing glycerol utilization
DK2185164T3 (en) COMPOSITION AND THERAPEUTIC ANTITUMORVACCINE
DK1984009T3 (en) Pharmaceutical compositions with improved stability
DK3263589T5 (en) PEPTIME SEQUENCES AND COMPOSITIONS
PL2356462T3 (en) Anti-CXCR1 compositions and methods
EP2043136A4 (en) FILMOGENE COMPOSITION
DK2373293T3 (en) COMPOSITIONS WITH REDUCED DIMERING
ZA200905508B (en) Compositions and methods to prevent cancer with cupredoxins
BRPI0905715A2 (en) Pharmaceutical Composition and Component Kit
DK3363857T3 (en) HYBRIDE HIGH POLYMER CONTENT REDUCING COMPOSITIONS
IL197602A0 (en) Compositions and methods to prevent cancer with cupredoxins
NO20081287A (en) Fuel composition and process for its preparation
FR2899479B1 (en) CICATRISANTE COMPOSITION
EP2034004A4 (en) GASOIL COMPOSITION
IL187138A0 (en) Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
BRPI0812932A2 (en) CANCER TREATMENT COMPOSITIONS AND METHODS
DK2152699T3 (en) Quinolone Compound and Pharmaceutical Composition

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application